Asset Dedication LLC’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-19
| Closed | -$12.1K | – | 1218 |
|
|
2025
Q1 | $12.1K | Buy |
19
+3
| +19% | +$1.9K | ﹤0.01% | 733 |
|
|
2024
Q4 | $11.4K | Buy |
16
+1
| +7% | +$712 | ﹤0.01% | 749 |
|
|
2024
Q3 | $15.8K | Hold |
15
| – | – | ﹤0.01% | 737 |
|
|
2024
Q2 | $15.8K | Hold |
15
| – | – | ﹤0.01% | 728 |
|
|
2024
Q1 | $14K | Hold |
15
| – | – | ﹤0.01% | 645 |
|
|
2023
Q4 | $13K | Hold |
15
| – | – | ﹤0.01% | 643 |
|
|
2023
Q3 | $12K | Buy |
+15
| New | +$12K | ﹤0.01% | 658 |
|
|
2022
Q1 | – | Sell |
-17
| Closed | -$11K | – | 1043 |
|
|
2021
Q4 | $11K | Hold |
17
| – | – | ﹤0.01% | 638 |
|
|
2021
Q3 | $10K | Buy |
+17
| New | +$10K | ﹤0.01% | 699 |
|
|
2020
Q3 | – | Sell |
-200
| Closed | -$125K | – | 780 |
|
|
2020
Q2 | $125K | Buy |
+200
| New | +$125K | 0.03% | 241 |
|
|
2019
Q4 | – | Sell |
-17
| Closed | -$5K | – | 812 |
|
|
2019
Q3 | $5K | Sell |
17
-21
| -55% | -$6.18K | ﹤0.01% | 509 |
|
|
2019
Q2 | $14K | Sell |
38
-5
| -12% | -$1.84K | ﹤0.01% | 398 |
|
|
2019
Q1 | $16K | Hold |
43
| – | – | 0.01% | 400 |
|
|
2018
Q4 | $16K | Sell |
43
-44
| -51% | -$16.4K | 0.01% | 384 |
|
|
2018
Q3 | $32K | Hold |
87
| – | – | 0.01% | 301 |
|
|
2018
Q2 | $32K | Sell |
87
-18
| -17% | -$6.62K | 0.01% | 317 |
|
|
2018
Q1 | $39K | Sell |
105
-32
| -23% | -$11.9K | 0.02% | 257 |
|
|
2017
Q4 | $50K | Sell |
137
-475
| -78% | -$173K | 0.02% | 243 |
|
|
2017
Q3 | $275K | Hold |
612
| – | – | 0.13% | 117 |
|
|
2017
Q2 | $290K | Hold |
612
| – | – | 0.15% | 120 |
|
|
2017
Q1 | $228K | Sell |
612
-8
| -1% | -$2.98K | 0.12% | 129 |
|
|
2016
Q4 | $227K | Buy |
620
+545
| +727% | +$200K | 0.13% | 128 |
|
|
2016
Q3 | $31K | Buy |
75
+3
| +4% | +$1.24K | 0.02% | 223 |
|
|
2016
Q2 | $23K | Hold |
72
| – | – | 0.02% | 228 |
|
|
2016
Q1 | $26K | Sell |
72
-18
| -20% | -$6.5K | 0.02% | 225 |
|
|
2015
Q4 | $49K | Buy |
+90
| New | +$49K | 0.03% | 237 |
|